Webinars - Abzena

With almost 20 years of experience in developing biologic products using specialist technology we offer a seamless service from early discovery to cGMP manufacturing. We know what can go wrong during development, so our integrated teams work to ensure delivery to market on time and on budget. Our customers trust us to do the right thing for their products, so we take the time to understand their projects and advise on the best route forwards.

Our team of experts have been busy over the last few months presenting at a number of virtual events. In case you were not able to attend you can view all of the presentations on demand now.

Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines.

In this webinar our Group Leader for Bioconjugation Chemistry, Dr Nicolas Camper talks about leveraging deep industry knowledge to support the appropriate target product profiling for the development of next-generation Antibody-Drug Conjugates (ADCs).

Watch the webinar

Pre-formulation: De-risking Development Programs to Ensure a Successful IND Filing.

Abzena Senior Scientist, Gary Watts describes what pre-formulation is, how it can be utilised, and why you should be interested in applications to streamline your drug programs. He also outlines the approaches developed by Abzena in applying pre-formulation to identify fundamental drug properties.

Watch the webinar

Elements for Smooth Technology Transfers of Biologics Manufacturing Processes.

Our head of Process Development Stuart Bussell discusses essential elements for the successful transfer of biologics manufacturing processes, including effective communications, complete and accurate information transfer, risk management, and clear success criteria.

Watch the webinar

Oligonucleotide ADC Design and Development – An Emerging Field Building on the Success of ADCs in Cancer.

In this webinar, our Bioconjugation experts Dr Matthew Bird and Dr Juan Carlos Cordova review oligonucleotide bioconjugates focusing upon their design, development, analysis and manufacture.

Watch the webinar

To find out more about our Biologics, Bioconjugate and Antibody Drug Conjugate capabilities, or if you have any questions relating to any of our presentations, please don’t hesitate to contact a member of the Abzena team today.

Interested in our services? Get In Touch